| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 31, 2003
From the Laboratory of Pneumology, Lung Toxicology Unit (A.N., P.H.M.H., B.N.), and the Center for Molecular and Vascular Biology (J.V., M.F.H.), Katholieke Universiteit Leuven, Leuven, Belgium. * To whom correspondence should be addressed. E-mail: ben.nemery{at}med.kuleuven.ac.be.
Background--Particulate air pollution is associated with cardiovascular diseases and myocardial infarction (MI). Methods and Results--We investigated the relationship between airway inflammation and thrombosis 24 hours after intratracheal (IT) instillation of diesel exhaust particles (DEP; 50 µg/hamster). Mild thrombosis was induced in the femoral vein by endothelial injury, and the consequences of airway inflammation on thrombogenicity were studied via online video microscopy. Lung inflammation and histamine analysis in bronchoalveolar lavage (BAL) and plasma were performed after pretreatment with dexamethasone (DEX) or sodium cromoglycate (SC). DEP induced airway inflammation and histamine release in BAL and in plasma, and increased thrombosis, without elevating plasma von Willebrand factor (vWF) levels. The IT instillation of 400-nm positively charged polystyrene particles (500 µg/hamster), serving as particles that do not penetrate into the circulation, equally produced airway inflammation, histamine release, and enhanced thrombosis. Histamine in plasma resulted from basophil activation. Intraperitoneal (IP) pretreatment with DEX (5 mg/kg) abolished the DEP-induced histamine increase in BAL and plasma and abrogated airway inflammation and thrombogenicity. The IT pretreatment with DEX (0.5 mg/kg) showed a partial but parallel inhibition of all of these parameters. Pretreatment with SC (40 mg/kg, IP) strongly inhibited airway inflammation, thrombogenicity, and histamine release. Conclusions--Our results are compatible with the triggering of mast cell degranulation and histamine release by DEP. Histamine plays an initial central role in airway inflammation, further release of histamine by circulating basophils, and peripheral thrombotic events. Antiinflammatory pretreatment can abrogate the peripheral thrombogenicity by preventing histamine release from mast cells.
Revised on April 29, 2004
Accepted on May 3, 2004
Pharmacological Stabilization of Mast Cells Abrogates Late Thrombotic Events Induced by Diesel Exhaust Particles in Hamsters
Abderrahim Nemmar DVM, PhD,
This article has been cited by other articles:
![]() |
J. P. Chen, D. Hou, L. Pendyala, J. A. Goudevenos, and N. G. Kounis Drug-Eluting Stent Thrombosis: The Kounis Hypersensitivity-Associated Acute Coronary Syndrome Revisited J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 583 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wijagkanalan, Y. Higuchi, S. Kawakami, M. Teshima, H. Sasaki, and M. Hashida Enhanced Anti-Inflammation of Inhaled Dexamethasone Palmitate Using Mannosylated Liposomes in an Endotoxin-Induced Lung Inflammation Model Mol. Pharmacol., November 1, 2008; 74(5): 1183 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Tankersley, H. C. Champion, E. Takimoto, K. Gabrielson, D. Bedja, V. Misra, H. El-Haddad, R. Rabold, and W. Mitzner Exposure to inhaled particulate matter impairs cardiac function in senescent mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R252 - R263. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Brook Air Pollution: What Is Bad for the Arteries Might Be Bad for the Veins Arch Intern Med, May 12, 2008; 168(9): 909 - 911. [Full Text] [PDF] |
||||
![]() |
A. Nemmar, K. Melghit, and B. H. Ali The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats Experimental Biology and Medicine, May 1, 2008; 233(5): 610 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Krivoshto, J. R. Richards, T. E. Albertson, and R. W. Derlet The Toxicity of Diesel Exhaust: Implications for Primary Care J Am Board Fam Med, January 1, 2008; 21(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Kounis, G. N. Kounis, S. N. Kouni, G. D. Soufras, C. Niarchos, and A. Mazarakis Allergic Reactions Following Implantation of Drug-Eluting Stents: A Manifestation of Kounis Syndrome? J. Am. Coll. Cardiol., August 1, 2006; 48(3): 592 - 593. [Full Text] [PDF] |
||||
![]() |
T. Nawrot, A. Nemmar, and B. Nemery Update in environmental and occupational medicine 2005. Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 948 - 952. [Full Text] [PDF] |
||||
![]() |
N. G. Kounis, G. N. Kounis, S. N. Kouni, and G. D. Soufras The heart, the brain, and the Kounis syndrome Eur. Heart J., March 2, 2006; 27(6): 757 - 757. [Full Text] [PDF] |
||||
![]() |
N. G Kounis, S. N Kouni, and C. M Koutsojannis Myocardial infarction after aspirin treatment, and Kounis syndrome J R Soc Med, June 1, 2005; 98(6): 296 - 296. [Full Text] [PDF] |
||||
![]() |
A. Nemmar, B. Nemery, P. H. M. Hoet, N. Van Rooijen, and M. F. Hoylaerts Silica Particles Enhance Peripheral Thrombosis: Key Role of Lung Macrophage-Neutrophil Cross-Talk Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 872 - 879. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |